HEMOGENYX PHARMACEUTICALS PLC
Research and experimental development on biotechnology
HEMOGENYX PHARMACEUTICALS PLC
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
6 Heddon Street London W1B 4BT England
Full company profile for HEMOGENYX PHARMACEUTICALS PLC (08401609), an active life sciences and medical technology company based in London, England. Incorporated 13 Feb 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2014–2024)
Cash in Bank
£159.00k
Net Assets
£853.00k
Total Liabilities
£3.36M
Turnover
N/A
Employees
16
Debt Ratio
80%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 7 funding rounds
Sign up to view complete fundraising history
Investors (4)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 4 | Nov 2020 | IPO |
| Investor 1 | Jan 2021 | IPO |
| Investor 2 | Sept 2023 | IPO |
See all 4 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Vladislav Sandler
Ceased 4 Oct 2018
Alexis Sandler
Ceased 4 Oct 2018
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 3 Mar 2026 | Confirmation Statement | Confirmation statement made on 13 Feb 2026 with no updates | |
| 27 Feb 2026 | Capital | Allotment of shares (GBP 14,047,368.7703) on 18 Feb 2026 | |
| 13 Feb 2026 | Capital | Allotment of shares (GBP 14,046,860.3603) on 13 Feb 2026 | |
| 29 Jan 2026 | Capital | Allotment of shares (GBP 14,042,293.2603) on 18 Nov 2025 | |
| 29 Jan 2026 | Capital | Allotment of shares (GBP 14,043,527.0303) on 16 Dec 2025 |
Confirmation statement made on 13 Feb 2026 with no updates
Allotment of shares (GBP 14,047,368.7703) on 18 Feb 2026
Allotment of shares (GBP 14,046,860.3603) on 13 Feb 2026
Allotment of shares (GBP 14,042,293.2603) on 18 Nov 2025
Allotment of shares (GBP 14,043,527.0303) on 16 Dec 2025
Recent Activity
Latest Activity
Confirmation statement made on 13 Feb 2026 with no updates
1 months ago on 3 Mar 2026
Allotment of shares (GBP 14,047,368.7703) on 18 Feb 2026
2 months ago on 27 Feb 2026
Allotment of shares (GBP 14,046,860.3603) on 13 Feb 2026
2 months ago on 13 Feb 2026
Allotment of shares (GBP 14,042,293.2603) on 18 Nov 2025
3 months ago on 29 Jan 2026
Allotment of shares (GBP 14,043,527.0303) on 16 Dec 2025
3 months ago on 29 Jan 2026